Tepilta®

null · MEDA Pharma GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tepilta®, covering 2022-02-07 to 2022-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Tepilta® Versus Oxetacaine, Antacids and Placebo [Phase 3]